Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.75 USD | +2.97% | +4.09% | -32.61% |
May. 03 | Inari Medical Insider Sold Shares Worth $1,619,047, According to a Recent SEC Filing | MT |
May. 01 | Inari Medical Shares Jump on Higher Q1 Revenue | MT |
Business Summary
Number of employees: 1,300
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Venous Thromboembolism
96.5
%
| - | - | 476 | 96.5 % | - |
Emerging Therapies
3.5
%
| - | - | 17 | 3.5 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
95.2
%
| 374 | 97.5 % | 470 | 95.2 % | +25.62% |
International
4.8
%
| 9 | 2.5 % | 24 | 4.8 % | +152.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hykes
CEO | Chief Executive Officer | 51 | 17-08-31 |
Mitchell Hill
DFI | Director of Finance/CFO | 65 | 19-02-28 |
Norman Nie
CTO | Chief Tech/Sci/R&D Officer | - | 19-03-31 |
Shon Chakrabarti
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas Tu
CTO | Chief Tech/Sci/R&D Officer | 51 | 19-06-30 |
Brian Strauss
CTO | Chief Tech/Sci/R&D Officer | - | 17-03-31 |
Paul Koehn
COO | Chief Operating Officer | 61 | - |
William Hoffman
BRD | Director/Board Member | 56 | 15-02-08 |
Angela Ahmad
LAW | General Counsel | - | 20-11-11 |
Eric Khairy
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Root
BRD | Director/Board Member | 64 | 11-08-31 |
Don Milder
CHM | Chairman | 70 | 11-08-31 |
Catherine Szyman
BRD | Director/Board Member | 57 | 19-10-31 |
William Hoffman
BRD | Director/Board Member | 56 | 15-02-08 |
Cynthia Lucchese
BRD | Director/Board Member | 63 | 19-10-31 |
Dana Mead
BRD | Director/Board Member | 64 | 21-09-30 |
Rebecca Chambers
BRD | Director/Board Member | 46 | 21-06-20 |
Andrew Hykes
CEO | Chief Executive Officer | 51 | 17-08-31 |
Robert Warner
BRD | Director/Board Member | 57 | 22-02-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,138,159 | 52,571,592 ( 90.43 %) | 0 | 90.43 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.61% | 2.54B | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
-5.53% | 5.33B | |
+42.58% | 5.1B | |
-19.05% | 4.05B | |
+10.80% | 1.99B | |
-0.74% | 1.99B |
- Stock Market
- Equities
- NARI Stock
- Company Inari Medical, Inc.